Asli's Bio
Asli advises Health-Tech companies on M&A and strategic financing transactions. She has led dozens of transactions, including acquisitions, as well as early stage investments. Asli’s domain expertise includes life sciences, diagnostics and medical devices. She brings immense expertise to WCP’s clients from her previous senior leadership roles in Strategy and Corporate Development at major global corporations, and her 17+ years of strategic planning, corporate development, mergers & acquisitions experience.
Before joining WCP, Asli was an Associate Vice President at Agilent Technologies where she was responsible for all aspects of the M&A process, including deal sourcing, performing a strategic and financial assessment, deal structuring, conducting due diligence, leading negotiations and successful completion of the deals. She has led more than 25 deals ranging in value from $10M – $1.5B.
Asli is passionate about helping companies to achieve their strategic goals. She holds a Ph.D. and MSc in finance, and is a graduate of the London School of Economics.
Asli's Focus
Digital Health
Asli's Thought Leadership
WCP Proudly Releases the Inaugural Healthcare Report “State of Digital Health”
Palo Alto, CA – April 23, 2018 In 2016, healthcare cost in the US was $3.3 Trillion – 17.9% of GDP, passing $10,000 per capita mark for the first time ever. According to CMS, by 2026, the figure is projected to grow to $5.7 Trillion – 19.8% of GDP.
